Cancer clinical trials in the region Nouvelle-Aquitaine
195 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Kidney cancer
#NCT06099782
Surgery
Grade 3
Grade 4
Immunotherapy
Bispecific T-cell engager antibodies
Radiotherapy
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT06099782
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT05967689
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), CHU Caen Normandie (Caen), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire Laennec (Saint-Herblain) (and 4 more...)
Taiho Oncology
Phase 2
Lung cancer
#NCT05925530
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Systemic Treatment-Naive
EGFR
ALK
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Grenoble (La Tronche), Hôpital de la Timone AP-HM (Marseille), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier) (and 1 more...)
AstraZeneca
Phase 2
Rectal cancer
#NCT05723562
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
MSS
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), CHU de Rennes - Hôpital Pontchaillou (Rennes), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2
Lung cancer
#NCT05688280
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Foch (Suresnes)
Immunophotonics
Phase 2
Rectal cancer
#NCT05591534
Adenocarcinoma
Locally Advanced
Radiotherapy
Centre Hospitalier Universitaire de Bordeaux (Bordeaux)
CHU de Bordeaux
Phase 2
Lung cancer
#NCT05565378
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
EGFR
ALK
Immunotherapy
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), CHU Caen Normandie (Caen), Hôpital de la Timone AP-HM (Marseille)
GlaxoSmithKline
Phase 2
Prostate cancer
#NCT05489211
Metastatic Castration-resistant
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre Léon Bérard (Lyon), Hôpital Foch (Suresnes)
AstraZeneca
Phase 2
Lung cancer
#NCT05403385
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
EGFR
ALK
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille) (and 4 more...)
iTeos Belgique SA